Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0061 |
Clofibric acid
Chlorofibrinic acid,氯贝酸 |
PPAR; Drug Metabolite | DNA Damage/DNA Repair; Metabolism |
Clofibric acid (Chlorofibrinic acid) 是一种脂质纤维调节剂 Clofibrate,Etofibrate 和 Etofyllinclofibrate 的活性代谢物,是 PPARα的激动剂,具有降血脂作用,也可作为除草剂。 | |||
T71305 |
Clofibric Acid-d4
|
||
Clofibric acid-d4 is intended for use as an internal standard for the quantification of clofibric acid by GC- or LC-MS. Clofibric acid is a peroxisome proliferator-activated receptor α (PPARα) agonist (EC50 = 50 µM in a transactivation assay) and the active metabolite of clofibrate. It is formed from clofibrate by tissue and serum esterases. Dietary administration of clofibric acid (0.067-0.22%) reduces serum cholesterol, phospholipid, and triglyceride levels in rats. It decreases glutamate oxal... | |||
T71981 |
Gliclazide-d4
|
||
Gliclazide-d4 is intended for use as an internal standard for the quantification of gliclazide by GC- or LC-MS. Gliclazide is a sulfonylurea and an inhibitor of pancreatic β-cell ATP-sensitive potassium (KATP) channels. It is selective for pancreatic β-cell over cardiac and arterial smooth muscle cell KATP channels. Gliclazide (5 μM) increases insulin-induced glucose uptake and glucose transporter 4 (GLUT4) translocation to the plasma membrane in a differentiated 3T3L1 adipocyte model of insulin... | |||
T21243 |
Aluminium clofibrate
Atherolip,Alfibrate,Alufibrate |
||
Aluminium clofibrate, a salt of clofibric acid, is a peroxisome proliferator. |